Example: dental hygienist
WHO GUIDELINES FOR DRAFTING A SITE MASTER FILE
A SMF for each manufacturing site of active pharmaceutical ingredient (API) and contract research organization (CRO), listed in a product dossier, should be submitted on ... computerized systems validation. Sanitation 3.10 Availability of written specifications and procedures for cleaning manufacturing areas and equipment. 4. Documentation
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Guidance on aspects of cleaning validation in active ...
apic.cefic.orgCleaning Validation Guidance 3 1.0 Foreword This document has been prepared by the cleaning validation task force within the active pharmaceutical ingredient committee (APIC) of CEFIC. In recent years the subject of cleaning validation in active pharmaceutical ingredient manufacturing plants has received a large amount of attention from regulators,
GUIDANCE ON ASPECTS OF CLEANING VALIDATION IN …
apic.cefic.orgThe subject of cleaning validation in active pharmaceutical ingredient manufacturing plants has continued to receive a large amount of attention from regulators, companies and customers alike. The integration of Cleaning Validation within an effective Quality System supported by
CLEANING VALIDATION WITH RISK ASSESSMENT
www.usp-pqm.orgUS FDA Draft Guidance for Manufacturing, Processing, or Holding Active Pharmaceutical Ingredients (1998) APIC Guide “Cleaning Validation in Active Pharmaceutical Ingredient Manufacturing Plants (1999)” & Companion Document “Guidance on Aspects of Cleaning Validation in Active Pharmaceutical Ingredient Plants (2000)”
Joint IPEC/PQG GMP Guide for Pharmaceutical Excipients
www.ipec-europe.orgappearance, stability and delivery of the active ingredient. Therefore, applying appropriate Good Manufacturing Practice (GMP) principles to excipients is essential. There are a large number of applications for this diverse range of materials which makes the development of excipient GMP guidelines challenging.